Keros Therapeutics Inc (KROS) — Free Cash Flow Generation Index
Keros Therapeutics Inc (KROS) has a Free Cash Flow Generation Index of 0.96x as of September 2025. Free cash flow of $3.12 Million represents 1% of operating cash flow ($3.25 Million). Explore reinvestment intensity of Keros Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Keros Therapeutics Inc Free Cash Flow Generation Index (2018–2018)
Historical FCF Generation Index trend for Keros Therapeutics Inc across 1 annual periods. For the full cash flow conversion analysis, see Keros Therapeutics Inc (KROS) cash conversion ratio.
Annual Free Cash Flow Generation for Keros Therapeutics Inc (2018–2018)
Year-by-year Free Cash Flow Generation Index for Keros Therapeutics Inc. Check how aggressively does Keros Therapeutics Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2018 | 0.97x | $6.83 Million | $7.04 Million | $217.00K | — |